No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MNMD250117C10000
- 0.06
- 0.000.00%
15min DelayTrading Jan 8 14:44 ET
0.00High0.00Low
0.00Open0.06Pre Close0 Volume5.02K Open Interest10.00Strike Price0.00Turnover181.34%IV47.53%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type0.0839Delta0.0894Gamma113.65Leverage Ratio-0.0179Theta0.0001Rho9.54Eff Leverage0.0015Vega
Intraday
- 5D
- Daily
News
Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member
Why Mind Medicine Stock Is Soaring Today
Institutional Investors Are Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) Biggest Bettors and Were Rewarded After Last Week's US$73m Market Cap Gain
MindMed Stock Skyrockets 94% Year to Date: What's Driving It?
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Mind Medicine Initiated at Buy by Chardan Capital